Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization

Genes Chromosomes and Cancer

Volumn 19, Issue 2, 1997, Pages 124-133

  Avet Loiseau, H ^a,b   Andree Ashley, L E ^a   Moore II, D ^a   Mellerin, M P ^b   Feusner, J ^a   Bataille, R ^b   Pallavicini, Maria G ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Hopital Mere Enfant CHU de Nantes   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CHROMOSOME ANALYSIS; CYTOGENETICS; DNA HYBRIDIZATION; HUMAN; HUMAN CELL; METAPHASE CHROMOSOME; MOLECULAR GENETICS; MULTIPLE MYELOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL;

DNA, NEOPLASM; GENE DOSAGE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKEMIA, PLASMACYTIC; MULTIPLE MYELOMA; NUCLEIC ACID HYBRIDIZATION; TUMOR CELLS, CULTURED;

EID: 0030957791     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199706)19:2<124::AID-GCC8>3.0.CO;2-0     Document Type: Article

References (50)

1. Ankathil, R, Mudhavan J, Gangadharan VP, Pillai GR, Nair MK (1995) Nonrandom karyotype abnormalities in 36 multiple myeloma patients. Cancer Genet Cytogenet 83:71-74.
2. Bentz, M, Dohner H, Werner CA, Huck K, Baudis M, Voos S, Schlegelberger B, Trumper LH, Feller AC, Pfreundschuh M, et al. (1995)a. Identification of genetic imbalances in malignant lymphoma using comparative genomic hybridization. Stem Cells 13:83-87.
3. Bentz, M, Huck K, du Manoir S, Joos S, Werner CA, Fischer K, Dohner H, Lichter P (1995)b. Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood 85:3610-3618.
4. Corradini, P, Inghirami G, Astolfi M, Ladetto M, Voena C, Ballerini P, Gu W, Nilsson K, Knowles DM, Boccadoro M, et al. (1994) Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias. Leukemia 8:758-767.
5. Dao, DD, Sawyer JR, Epstein J, Hoover RG, Barlogie B, Tricot G (1994) Deletion of the retinoblastoma gene in multiple myeloma. Leukemia 8:1280-1284.
6. Dewald, GW, Kyle RA, Hicks GA, Greipp PR (1985) The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 66:380-390.
7. Dihal, V, Schaadt M, Kirchner H, Hulliagel KP, Quadal F, Fonatesh E, Laskewitz R, Guggenheim R (1978) Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCI) in vitro: A comparative study. Blut 36:331-338.
8. Dimopoulos, MA, Palumbo A, Delasalle KB, Alexanian R (1994) Primary plasma cell leukaemia. Br J Haematol 88:754-759.
9. Drach, J, Schuster J, Nowotny H, Angerler J, Rosenthal F, Fiegl M, Rothermundt C, Gsur A, Jager U, Heinz R, et al. (1995) Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Res 55:3854-3385
10. du Manoir, S, Schrock E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T (1995) Quantitative analysis of comparative genomic hybridization. Cytometry 19:27-41.
11. Dubinsky, R, Amiel A, Manor Y, Radnay Y, Fejgin M, Ravid M, Lishner M (1995) Fluorescence in situ hybridization (FISH) for retrospective detection of trisomies 3 and 7 in multiple myeloma. Cancer Genet Cytogenet 83:115-118.
12. Durie, BGM (1992) Cellular and Molecular Genetic Features of Myeloma and Related Disorders. Philadelphia, WB Saunders pp 463-477.
13. Facon, T, Lai JL, Nataf E, Preudhomme C, Zandecki M, Hammad M, Wattel E, Jouet JP, Bauters F (1993) Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: A report on 46 patients. Br J Haematol 84:743-745.
14. Gould, J, Alexanian R, Goodacre A, Pathak S, Hecht B, Barlogie B (1988) Plasma cell karyotype in multiple myeloma. Blood 71:453-456.
15. Gray, JW, Kuo WL, Pinkel D (1991) Molecular cytometry applied to detection and characterization of disease-linked chromosome aberrations. Baillieres Clin Haematol 4:683-693.
16. Gray, JW, Pinkel D (1992) Molecular cytogenetics in human cancer diagnosis. Cancer 69:1536-1542.
17. Gutensohn, K, Weh HJ, Walter TA, Hossfeld DK ( 1992) Cytogenetics in multiple myeloma and plasma cell leukemia: Simultaneous cytogenetic and cytologic studies in 51 patients. Ann Hematol 65:88-90.
18. Gutensohn, K, Selbach J, Kruse R, Wacker-Backhaus G, Seeger D, Fiedler W, Fett W, Hossfeld DK (1993) Karyotype in multiple myelom and plasma cell leukemia. Eur J Cancer 29a:1269-1273.
19. Heim, S, Mitelman F (1995) Cancer Cytogenetics, Second Ed. New York: Wiley-Liss pp 237-256.
20. Jelinek, DF, Ahmann GJ, Grolpp PR, Jalal EM, Westerndorf JJ, Katzmann JA, Kyle RA, Lust JA (1993) Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: Clinical implications. Cancer Res. 53:5330-5337.
21. Johnson, GD, Nogueria JGM (1981) A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods 43:349-350.
22. Juge-Morineau, N, Francois S, Puthier D, Godard A, Bataille R, Amiot M (1995) The gp 130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the anti-proliferative effect of dexamethasone on human myeloma cells. Br J Haematol 90:707-710.
23. ISCN (1995): Mitelman, F (ed): An International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 1995.
24. Kallioniemi, A, Kallioniemi OP, Citro G, Sauter G, DeVries S, Kerschmann R, Caroll P, Waldman F (1995) Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosom Cancer 12:213-219.
25. Kallioniemi, A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Gray JW, Waldman FM (1994a) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91:2156-2160.
26. Kallioniemi, A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
27. Kallioniemi, OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D (1994b) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 10:231-243.
28. Katagiri, S, Yonezawa T, Kuyama J, Kanayama Y, Nishida K, Abe T, Tamaki T, Ohnishi M, Tarui S (1985) Two distinct human myeloma cell lines origination from one patient with myeloma. Int J Cancer 36:241-248.
29. Kowalczyk, JR, Dmoszynska A, Chobotow M, Sokolowska B (1991) Cytogenetic studies in patients with multiple myeloma. Cancer Genet Cytogenet 55:173-174.
30. Lai, JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T (1995) Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 85:2490-2497.
31. Latreille, J, Barlogie B, Gohde W, Johnston D, Drewinko B, Alexanian R (1980) Cellular DNA content as a marker of human multiple myeloma. Blood 55:403-408.
32. Lee, W, Han K, Drut RM, Harris CP, Meisner LF (1993) Use of fluorescence in situ hybridization for retrospective detection of aneuploidy in multiple myeloma. Genes Chromosom Cancer 7:137-143.
33. Matsukuo, Y, Moore GE, Yagi Y, Pressman D (1967) Progression of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc. Soc. Exp. Biol. Med 125:1246-1250.
34. Monni, O, Joensuu H, Franssila K, Knuutila S (1996) DNA copy number changes in diffuse large B-cell lymphoma. Blood 87: 5269-5278.
35. Moore, OH II, Pallauicini MG, Cher ML, Pinnel D, Gray UW (1997) A t-statistic for objective interpretation of comparative genomic hybridization (CGH) profiles. (In press).
36. Moscinski, LC, Ballester OF (1994) Recent progress in multiple mMyelnma. Hematol Oncol 12:111-113.
37. Nilsson, K, Bennich H, Johansson SGO, Ponton J (1970) Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from and IgE myeloma patient. Clin Exp Immunol 7:477-489.
38. Pegoraro, L, Malavasi F, Bellone G, Massala M, Boccadoro M, Saglio G, Guerrasio A, Benetton G, Lombardi L, Coda R, Avanzi GC (1989) The human myeloma cell line UP-: A versatile model in which to study early plasma-cell differentiation and c-myc activation. Blood 73:1020-1027.
39. Perez, Lossada, A, Woessner S, Sole F, Florensa L, Bonet C (1994) (chromosomal and in vitro culture studies in a case of primary plasma cell leukemia. Cancer Genet Cytogenet 76:36-38.
40. Pinkel, D, Landegent J, Collins C, Fuscoe J, Segraves R, Lucas J, Gray J (1988) Fluorescence in situ hybridization with human chromosome-specific libraries: Detection of trisomy 21 and translocation 4. Proc Natl Acad Sci USA 85:938-9142.
41. Piper, J, Rutovitz, D, Sudar D, Kallioniemi A, Kallioniemi OP, Waldman FM, Gray JW, Pinkel D (1995) Computer image analysis of comparative genomic hybridisation. Cytometry 19:10-26.
42. Sambrook, J, Fritsch EF, Maniatis T (1989) Molecular cloning: A laboratory manual. Plainview, NY: Cold Spring Harbor Laboratory Press.
43. Sandberg, AA (1989) Chromosomes in Cancer and Leukemia. Klsevier, New York.
44. Sawyer, JR, Waldron JA, Jagannath S, Barlogie B (1995) Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 82:41-49.
45. Taniwaki, M, Nishida K, Takashima T, Nakagawa H, Fujii H, Tamaki T, Shimazaki C, Horiike S, Misawa S, Abe T, et al. (1994) Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood 84:2283-2290.
46. Tricot, G, Barlogie B. Jagannath S, Bracy D, Mattox S, Vesole DH, Naucke S, Sawyer JR (1995) Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 86:4250-4256.
47. van den Berghe. H (1990) Chromosomes in plasma-cell malignancies. Eur. J. Hematol 3:47-51.
48. Weh, HJ, Fiedler W, Hossfeld DK (1990) Cytogeneties in multiple myeloma: Are we studying the 'right' cells? [letter]. Eur J Haematol 45:236-237.
49. Weh, HJ, Gutensohn K, Selbach J, Kruse R, Wacker-Backhaus G, Seeger D, Fiedler W, Fett W, Hossfeld DK (1993) Karyotype in multiple myeloma and plasma cell leukaemia. Kur J Cancer 29A:1269-1273.
50. Zhang, XG, Gaillard JP, Robillard N, Lu ZY, Gu ZJ, Jourdan M, Boiron JM, Bataille R. Klein B (1994) Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 83:3654-3663.